{
  "item1": "A/A+ properties undergoing construction develop dynamic Megacampus ecosystems enable inspire world’s most brilliant minds innovative companies create life-changing scientific technological innovations. believe utmost professionalism, humility, teamwork. tenants include multinational pharmaceutical companies; public private biotechnology companies; life science product, service, medical device companies; digital health, technology, agtech companies; academic medical research institutions; U.S. government research agencies; non-profit organizations; venture capital firms.",
  "item7": "tenants, many which conduct business life science industry, may incur significant costs losses responding any highly infectious contagious disease, lose business due interruption operations, incur other liabilities related shelter-in-place orders, quarantines, infection, other related factors. Tenants experience deteriorating financial conditions result outbreak spread such disease may unwilling unable pay rent full timely due bankruptcy, lack liquidity, lack funding, operational failures, other reasons. tenants’ defaults delayed partial rental payments could adversely impact rental revenues operating results. negative effects any highly infectious contagious disease tenants life science industry may include, but Delays difficulties enrolling patients maintaining scheduled study visits clinical trials; Delays difficulties clinical site initiation, including difficulties recruiting clinical site investigators staff; Diversion healthcare resources away clinical trials, including diversion hospitals serving tenants’ clinical trial sites hospital staff supporting conduct tenants’ clinical trials; Interruptions key clinical trial other research activities, such clinical trial site monitoring, due limitations travel imposed recommended federal state governments, employers, others; Limitations employee resources would otherwise focused tenants’ research, business, clinical trials, including because sickness employees families, desire employees avoid contact large groups people, result governmental imposition shelter-in-place similar working restrictions; Interruptions supply chain, manufacturing, global shipping, other delays may affect transport materials necessary tenants’ research, clinical trials, manufacturing activities; Reduction revenue projections tenants’ products due prioritization treatment affected patients over other treatments, such specialty elective procedures; Delays necessary interactions ethics committees, regulators, other important agencies contractors due limitations employee resources forced furlough government employees; Delays receiving approval regulatory authorities initiate planned clinical trials research activities; Delays commercialization tenants’ products approval government authorities (such FDA federal state Emergency Management Agencies) tenants’ products caused disruptions, funding shortages, health concerns, well prioritization FDA review approvals diagnostics, therapeutics, vaccines related outbreak; Difficulty retaining staff rehiring staff connection layoffs caused deteriorating global market conditions; Changes local regulations part response outbreak spread may require tenants change ways which clinical trials conducted, which may result unexpected costs discontinuation clinical Refusal reluctance FDA accept data clinical trials affected geographies outside U.S.; Diminishing public trust healthcare facilities other facilities treating (or treated) patients affected contagious diseases; Inability access capital terms favorable tenants because changes company valuation and/or investor appetite due general downturn economic financial conditions volatility market.",
  "item2": "ITEM 2. MANAGEMENT’S DISCUSSION ANALYSIS FINANCIAL CONDITION RESULTS OPERATIONS Forward-looking statements containing words “forecast,” “guidance,” “goals,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,” “seeks,” “should,” “targets,” “will,” negative those words similar words, constitute “forward-looking statements” within meaning Section 27A Securities Act 1933, amended, Section 21E Securities Exchange Act 1934, amended. Forward-looking statements involve inherent risks uncertainties regarding events, conditions, financial trends may affect future plans operations, business strategy, results operations, financial position. number important factors could cause actual results differ materially those included within contemplated forward-looking statements, including, but not limited to, following: Operating factors, such failure operate business successfully comparison market expectations comparison competitors, inability obtain capital when desired refinance debt maturities when desired, and/ failure maintain status REIT federal tax purposes; Market industry factors, such adverse developments concerning life science industry and/or tenants; Government factors, such any unfavorable effects resulting federal, state, local, and/or foreign government policies, laws, and/or funding levels; Global factors, such negative economic, social, political, financial, credit market, banking conditions, and/or regional armed hostilities; Other factors, such climate change, cyber intrusions, and/or changes laws, regulations, financial accounting Global trade policies been monitoring will continue monitor macroeconomic trends uncertainties."
}